Cancer Treatment and Research Communications
Cancer Treat Res Commun
Biomedical Researchers, Clinical Pharmacologists, Clinicians, Immunologists, Interventionalists, Molecular Biologists, Nuclear Medicine Physicians, Oncologists, Pathologists, Physicians, Policy Makers, Radiation Oncologists, Researchers, Residents
Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.
Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.
No associations affiliated with this journal
Elsevier Ltd. - London
Author Submission Guidelines
To see more details about Cancer Treatment and Research Communications, Subscribe Now!